Growth Metrics

Whitehawk Therapeutics (WHWK) Net Income towards Common Stockholders Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -58.11%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -95.76%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -290.15%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 59.59%
7 Evaxion A 62.56 Bn 62.54 Bn - -129.68%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -10.08%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1,228.66%
10 Whitehawk Therapeutics 312.26 Mn 189.22 Mn - -130.40%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -130.40%
Dec 31, 2025 575.01%
Sep 30, 2025 -41.06%
Jun 30, 2025 -261.91%
Mar 31, 2025 499.26%
Dec 31, 2024 -12.32%
Sep 30, 2024 23.05%
Jun 30, 2024 18.86%
Mar 31, 2024 -20.13%
Dec 31, 2023 -16.93%
Sep 30, 2023 -12.63%
Jun 30, 2023 1.63%
Mar 31, 2023 -9.86%
Dec 31, 2022 12.99%
Sep 30, 2022 83.38%
Jun 30, 2022 -314.46%
Mar 31, 2022 -211.97%
Dec 31, 2021 -299.40%
Sep 30, 2021 -2,912.38%
Jun 30, 2021 -147.52%
Mar 31, 2021 -13.35%
Dec 31, 2020 280.36%
Sep 30, 2020 37.80%
Jun 30, 2020 263.21%
Mar 31, 2020 53.86%
Dec 31, 2019 47.81%
Sep 30, 2019 -140.29%
Jun 30, 2019 5.11%
Mar 31, 2019 -14.37%
Dec 31, 2018 -36.62%
Sep 30, 2018 348.14%
Jun 30, 2018 -8.51%
Mar 31, 2018 -25.03%
Dec 31, 2017 -36.36%
Sep 30, 2017 21.73%
Jun 30, 2017 -6.38%
Mar 31, 2017 -13.99%
Dec 31, 2016 -38,546.06%
Sep 30, 2016 -90,994.28%
Jun 30, 2016 -71,258.07%
Mar 31, 2016 -89,497.06%
Dec 31, 2015 -1.54%
Sep 30, 2015 -1.45%
Jun 30, 2015 -4.60%
Mar 31, 2015 -0.85%
Dec 31, 2014 -19.52%
Sep 30, 2014 -4.71%
Jun 30, 2014 -3.01%
Mar 31, 2014 4.90%
Dec 31, 2013 -0.91%
Sep 30, 2013 -1.67%
Jun 30, 2013 -7.08%
Mar 31, 2013 -13.07%
Dec 31, 2012 -8.15%
Sep 30, 2012 4.72%
Jun 30, 2012 6.76%
Mar 31, 2012 -4.04%
Dec 31, 2011 -15.34%
Sep 30, 2011 -32.93%